SUSRF (Surgical Science Sweden AB) Growth Rank: 10 (As of Aug. 01, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SUSRF Surgical Science Sweden AB SUSRF
85 GF Score
Price $4.00
GF Value $19.89
! 4 Warning Signs
View Full Analysis

What is Surgical Science Sweden AB Growth Rank?

Surgical Science Sweden AB SUSRF -2.20% 85 Growth Rank is 10 as of Aug. 01, 2026, which is at its 10-year median of 10.00. GuruFocus rates SUSRF with a GF Score™ of 85/100 and a GF Value™ of $19.89. The stock has 4 warning signs investors should review.

Surgical Science Sweden AB has the Growth Rank of 10.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Surgical Science Sweden AB Growth Rank Related Terms

SUSRF vs VEEV, BTSG, HQY: Growth Rank Comparison

For the Health Information Services subindustry, Surgical Science Sweden AB's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Surgical Science Sweden AB Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's Growth Rank distribution charts can be found below:

* The bar in red indicates where Surgical Science Sweden AB's Growth Rank falls into.


SUSRF
85GF Score
Surgical Science Sweden AB SUSRF
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 10 mean?
Surgical Science Sweden AB (SUSRF) has a Growth Rank of 10 as of Aug. 01, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Surgical Science Sweden AB and its competitors. This is near median its historical median of 10.00. Over the past decade, Surgical Science Sweden AB's Growth Rank has ranged from 5.00 to 10.00.
Is Surgical Science Sweden AB's Growth Rank too high?
Surgical Science Sweden AB's current Growth Rank of 10 is near median its 10-year median of 10.00. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 10.00. Overall, Surgical Science Sweden AB has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's Growth Rank compare to VEEV and BTSG?
Surgical Science Sweden AB's Growth Rank of 10 can be compared against companies in the Healthcare Providers & Services industry. Historically, Surgical Science Sweden AB's own Growth Rank has ranged from 5.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Surgical Science Sweden AB and its competitors. Surgical Science Sweden AB's current Growth Rank is 10, which is near median its own 10-year median of 10.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Surgical Science Sweden AB (SUSRF) has a current Growth Rank of 10. The stock's GF Value™ is $19.89, compared to a current price of $4.00 — trading 79.9% below its estimated fair value. The current Growth Rank is 10, which is near median its 10-year median of 10.00. Surgical Science Sweden AB's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Surgical Science Sweden AB (SUSRF), the current Growth Rank is 10 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Surgical Science Sweden AB (SUSRF) Overvalued in 2026?

Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued. The current stock price of $4.00 is trading 79.9% below its estimated GF Value™ of $19.89.

Key valuation signals for SUSRF:

  • Growth Rank: 10 (near median its 10-year median of 10.00)
  • GF Value™: $19.89 vs. price of $4.00 (79.9% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the SUSRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Surgical Science Sweden AB Business Description

Other Exchanges SUS:Sweden4P41:Germany
Address Drakegatan 7A, Gothenburg, SWE, SE-412 50
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
85GF Score

Get the complete analysis for SUSRF

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.00
Price
$19.89
GF Value